Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Gastrointestinal Cancer

Breast Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Gastrointestinal Cancer

Nivolumab Approved in Japan for Esophageal Cancer

The Japanese Ministry of Health, Labor and Welfare has approved nivolumab for the treatment of patients with unresectable advanced or recurrent esophageal cancer that has progressed following chemotherapy.
Read More >>

Research Efforts Poised to Redefine Role of Immunotherapy in mCRC

Ongoing Studies May Clarify Role of ADCs in Gastric Cancer and CRC

Emerging Combos Lead to More Questions, Research Efforts in Advanced HCC

Nivolumab/Cabiralizumab Combo Misses PFS Endpoint in Pancreatic Cancer

Immunotherapy Combos Emerging in HCC Armamentarium

View More Stories >>

View Conference Coverage

2020 Transplantation & Cellular Therapy Meetings

2020 Winter Lung Cancer Conference

2020 Genitourinary Cancers Symposium

2020 SGO Winter Meeting

2020 Gastrointestinal Cancers Symposium

Dr. Eng on Increasing Awareness for Adolescents/Young Adults With CRC

Dr. Ilson on Investigative TKI Combinations in Gastric Cancer

Dr. Lockhart on Dual-Immunotherapy Strategies in CRC

Dr. O'Reilly on the Utility of PARP Inhibitors in Pancreatic Cancer

Dr. Abou-Alfa on Progress Made in Hepatocellular Carcinoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Final Thoughts on CCA

ClarIDHy Phase III Trial of Ivosidenib in CCA

Hepatocellular Carcinoma: Future Directions in Care

Perioperative Approaches to HCC Management

Ivosidenib for Advanced IDH1-Mutated CCA

OncLive houses thousands of videos that provide updates and information.
See more Videos

Molecular Testing for Metastatic CRC in 2020

Targeting HER2 Outside of Breast Cancer

Novel Therapies for BRAF+ Colorectal Cancer

Targeting BRAF and MEK in Colorectal Cancer

The Future of Personalized Therapy in Advanced HCC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

PEGPH20: A Novel Agent for Pancreatic Adenocarcinoma

Andrew Ko, MD, professor, Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, provides insight on PEGPH20 for patients with pancreatic adenocarcinoma. View Now

Sequencing Decisions in Gastroesophageal Cancers

Led by Johanna Bendell, MD, panelists Ian Chau, MD; Yelena Y. Janjigian, MD; Manish A. Shah, MD; and Kohei Shitara, MD, focus on sequencing decisions for patients with gastroesophageal cancers. View Now

Featured Video

Dr. Marshall on Physician Burnout in Oncology

John L. Marshall, MD, of Medstar Georgetown University Hospital, Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer, Georgetown-Lombardi Comprehensive Cancer Center, discusses physician burnout in oncology. View now

OncLive News Network On Location: GU 2020 Day 3